EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Concerted and multidisciplinary management of COVID-19 drug therapies during the first two epidemic waves in a tertiary hospital in Marseille, France: Results of the PHARMA-COVID study

Matthieu Peretti iD, Stanislas Rebaudet, Laurent Chiche iD, Hervé Pegliasco, Emilie Coquet iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0283165 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift PLOS ONE, 2023. Verfasst von Matthieu Peretti und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service de Pharmacie, Hôpital Européen, Marseille, France. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the impact of local therapeutic recommendation updates made by the COVID multidisciplinary consultation meeting (RCP) at the Hôpital Européen Marseille (HEM) through the description of the drug prescriptions for COVID-19 during the first two waves of the epidemic.

Methods

This retrospective observational study analysed data from the hospital’s pharmaceutical file. We included all patients hospitalized for COVID-19 between February 1, 2020 and January 21, 2021 and extracted specific anti-COVID-19 therapies (ST) from computerized patient record, as well as patients’ demographic characteristics, comorbidities and outcome. The evolution of ST prescriptions during the study period was described and put into perspective with the updates of local recommendations made during the first (V1, from 2/24/2020 to 7/27/2020), and second (V2, from 7/28/2020 to 1/21/2021) epidemic waves.

Results

A total of 607 COVID-19 hospitalized patients, 197 during V1 and 410 during V2. Their mean age was 65 years-old, and they presented frequent comorbidities. In total, 93% of hospitalized patients received ST: anticoagulants (90%), glucocorticoids (39%) mainly during V2 (49% vs 17%, P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19HumansAgedSARS-CoV-2COVID-19 Drug TreatmentTertiary Care CentersLopinavirRitonavirHydroxychloroquineAntiviral Agents

Substanzen

LopinavirRitonavirHydroxychloroquineAntiviral Agents

Autor:innen und Institutionen

  • Service de Pharmacie, Hôpital Européen, Marseille, France.
  • Service d'Infectiologie et de Médecine Interne, Hôpital Européen, Marseille, France.
  • UMR1252 SESSTIM, Aix-Marseille Univ, Inserm, IRD, ISSPAM, Marseille, France.
  • Service de Pneumologie, Hôpital Européen, Marseille, France.

ORCID-Profile: Matthieu Peretti, Laurent Chiche, Emilie Coquet

Zitieren

APA

Peretti, M., Rebaudet, S., Chiche, L., Pegliasco, H., & Coquet, E. (2023). Concerted and multidisciplinary management of COVID-19 drug therapies during the first two epidemic waves in a tertiary hospital in Marseille, France: Results of the PHARMA-COVID study. PLOS ONE. https://doi.org/10.1371/journal.pone.0283165

Vancouver

Peretti M, Rebaudet S, Chiche L, Pegliasco H, Coquet E. Concerted and multidisciplinary management of COVID-19 drug therapies during the first two epidemic waves in a tertiary hospital in Marseille, France: Results of the PHARMA-COVID study. PLOS ONE. 2023. doi:10.1371/journal.pone.0283165

BibTeX
@article{Peretti2023,
  author = {Peretti, Matthieu and Rebaudet, Stanislas and Chiche, Laurent and Pegliasco, Hervé and Coquet, Emilie},
  title = {Concerted and multidisciplinary management of COVID-19 drug therapies during the first two epidemic waves in a tertiary hospital in Marseille, France: Results of the PHARMA-COVID study},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0283165}
}
Kostenlos starten →